Icelandic
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

diabetes mellitus type 2/albumin

Krækjan er vistuð á klemmuspjaldið
5 niðurstöður

Treatment of type 2 diabetes mellitus patients

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
This application claims the benefit of European Application No. 15 159 733.3, filed Mar. 18, 2015, and European Application No. 15 191 585.7, filed Oct. 27, 2015, the disclosures of which are herein incorporated by reference in their entirety. Subject of the present invention is

Methods and compositions using sulodexide for the treatment of diabetic nephropathy

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION The present invention relates to pharmaceutical compositions comprising Sulodexide in specific dosages and methods of using specific dosages of Sulodexide for the treatment of patients with diabetic nephropathy and albuminuria caused by, for example, insulin dependent or

Peptides derivatized with A-B-C-D- and their therapeutical use

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION This invention relates to the field of therapeutic peptides, i.e. to new protracted peptides derivatized with A-B-C-D, and their therapeutical use. Examples of therapeutic peptides of particular relevance for the present invention are Glucagon-Like Peptide-1 (GLP-1) and

Glucagon-like peptide-1 derivatives and their pharmaceutical use

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
SEQUENCE LISTING The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Feb. 4, 2010, is named 7668204US_SeqList.txt and is 5,582 bytes in size. FIELD OF THE

Glucagon-Like Peptide-1 derivatives and their pharmaceutical use

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
CROSS-REFERENCE TO RELATED APPLICATIONS This application is a 35 U.S.C. .sctn.371 national stage application of International Patent Application PCT/EP2008/061755 (published as WO 2009/030738), filed Sep. 5, 2008, which claimed priority of European Patent Applications 07115746.5, filed Sep. 5, 2007
Skráðu þig á
facebook síðu okkar

Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum

  • Virkar á 55 tungumálum
  • Jurtalækningar studdir af vísindum
  • Jurtaviðurkenning eftir ímynd
  • Gagnvirkt GPS kort - merktu jurtir á staðsetningu (kemur fljótlega)
  • Lestu vísindarit sem tengjast leit þinni
  • Leitaðu að lækningajurtum eftir áhrifum þeirra
  • Skipuleggðu áhugamál þitt og vertu vakandi með fréttarannsóknum, klínískum rannsóknum og einkaleyfum

Sláðu inn einkenni eða sjúkdóm og lestu um jurtir sem gætu hjálpað, sláðu jurt og sjáðu sjúkdóma og einkenni sem hún er notuð við.
* Allar upplýsingar eru byggðar á birtum vísindarannsóknum

Google Play badgeApp Store badge